Board Appointment—Dr. John Pollack, MD, FASRS

Dr. John Pollack, MD, FASRS, retina specialist and industry leader, joined PulseMedica’s Board of Directors strengthening clinical oversight and strategic alignment toward our FIH treatment study and beyond.

About Dr. John Pollack

Dr. John Pollack, MD, FASRS, is a retina surgeon, educator, and ophthalmology-focused entrepreneur and investor recognized for leadership across clinical practice, executive roles in biotechnology, company creation, and leadership within the retina community. He is a Partner at Illinois Retina Associates and a faculty member at Rush University Medical Center. Dr. Pollack has delivered more than 200 presentations at national and international meetings, published over 60 scientific papers and book chapters, and contributed to numerous national clinical trials as Study Chairman, Principal Investigator, and Co-Investigator.

In addition to his clinical work, Dr. Pollack serves as Chief Medical Officer of jCyte and previously served as CMO of Neurotech. His current and prior board roles include InnSight Technologies, Notal Vision, Illinois Retina Associates, the American Society of Retina Specialists (ASRS), and the Illinois Society for the Prevention of Blindness. He is the past President of ASRS and its Foundation, served 18 years on the ASRS Board of Directors, and was the co-founding Editor of the annual ASRS Preferences and Trends (PAT) Survey, which remains the largest international survey of medical and surgical trends in retina.

Dr. Pollack has co-founded multiple companies across ophthalmology, including Vestrum Health (healthcare data analytics, acquired by CorEvitas), Covalent Medical (Focus Vision Supplements), Clarus Acuity Group (boutique medical market research), and Sanulus Medical (retinal device development). He also co-founded The Winning Pitch Challenge, an innovation forum modelled after Shark Tank that supports the advancement of novel ideas through early development.